NCT06817291

Brief Summary

Laparoscopic endobiliary stent and postponed endoscopic retrograde cholangiopancreatography, ERCP, compared to intraoperative ERCP for the treatment of common bile duct stones, CBDS, a retrospective registry based cohort study. Data will be collected from GallRiks, the Swedish national registry for cholecystectomies and ERCP. Patients in the registry identified with found of CBDS at intraoperative cholangiography, IOC, and there after treated with ERCP during 2010-01-01 to 2023-12-31 are the study population. Research question: In patients with intraoperatively diagnosed CBDS - is there a difference in complications between laparoparoscopic endobiliary stent with postoperative ERCP, and intraoperative ERCP? Primary outcome: Complications within 30 days after cholecystectomy and the following ERCP. Secondary outcomes: 30 day mortality, procedure time for cholecystectomy, procedure time for ERCP, difficult cannulation, stone clearance at ERCP, cumulative hospital stay, readmission within 30 days after cholecystectomy/ERCP

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 24, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
Last Updated

February 10, 2025

Status Verified

February 1, 2025

Enrollment Period

8 months

First QC Date

January 24, 2025

Last Update Submit

February 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complication after cholecystectomy and the following ERCP

    Number of participants with treatment-related adverse events such as pancreatitis, cholangitis, bleeding, infection, gall leakage

    30 days after each procedure

Study Arms (2)

Laparoscopic endobiliary stent and postponed ERCP

Intraoperatively found common bile duct stones treated with laparoscopic endobiliaty stent and postoperative ERCP

Procedure: Laparoscopic endobiliary stent

Intraoperativ ERCP

Intraoperatively found common bile duct stones treated with intraoperative ERCP

Interventions

During laparoscopic gallblader surgery, a quidewire is inserted in the cystic duct, via the common bile duct and advanced into the duodenum. The plastic stent is threaded over the wire and pushed in position, with a catheter. When the stent is crossing the papilla, the wire is first removed, and then the catheter. The procedure is done under x-ray guidance.

Laparoscopic endobiliary stent and postponed ERCP

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be identified in the GallRiks registry with found of CBDS at intraoperative cholangiography, IOC, and thereafter treated with ERCP during 2010-01-01 to 2023-12-31.

You may qualify if:

  • Laparoscopic choleystectomy with intraoperative found of common bile duct stones by intraoperative cholangiography.
  • Common bile duct treated with laparoscopic endobiliary stent and postponed ERCP or intraoperative ERCP

You may not qualify if:

  • Other types of treatment for common bile duct stones Conversion to or open cholecystectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Sciences, Danderyd Hospital

Stockholm, Sweden

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

January 24, 2025

First Posted

February 10, 2025

Study Start

March 20, 2024

Primary Completion

November 11, 2024

Study Completion

November 11, 2024

Last Updated

February 10, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations